Inventor
SHEPPARD GEORGE S
US32 patents
⚠️ This page may combine multiple inventors who share the name “SHEPPARD GEORGE S”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ABBOTT LAB
19 patentsUS5486525AJan 23, 1996
Platelet activating factor antagonists: imidazopyridine indoles
ABBOTT LAB136 citations96
US7772231B2Aug 10, 2010
Substituted pyrazolo[3,4-d]pyrimidines as protein kinase inhibitors
ABBOTT LAB68 citations95
US5567711AOct 22, 1996
Indole-3-carbonyl and indole-3-sulfonyl derivatives as platelet activating factor antagonists
ABBOTT LAB59 citations95
US7030262B2Apr 18, 2006
3-Amino-2-hydroxyalkanoic acids and their prodrugs
ABBOTT LAB42 citations92
US5952320ASep 14, 1999
Macrocyclic inhibitors of matrix metalloproteinases and TNFα secretion
ABBOTT LAB34 citations92
US5654305AAug 5, 1997
Indole piperazine platelet activating factor antagonists
ABBOTT LAB35 citations92
US6288228B1Sep 11, 2001
Triazine angiogenesis inhibitors
ABBOTT LAB37 citations91
US7491718B2Feb 17, 2009
Sulfonamides having antiangiogenic and anticancer activity
ABBOTT LAB35 citations90
US6242494B1Jun 5, 2001
Substituted β-amino acid inhibitors of methionine aminopeptidase-2
ABBOTT LAB47 citations90
US5665777ASep 9, 1997
Biphenyl hydroxamate inhibitors of matrix metalloproteinases
ABBOTT LAB24 citations90
US6887863B2May 3, 2005
Hydrazide and alkoxyamide angiogenesis inhibitors
ABBOTT LAB32 citations89
US5643922AJul 1, 1997
Indole cyclohexyl platelet activating factor antagonists
ABBOTT LAB9 citations74
US6849757B2Feb 1, 2005
Antiangiogenic drug to treat cancer, arthritis and retinopathy
ABBOTT LAB9 citations73
US6632961B1Oct 14, 2003
Antiangiogenic drug to treat cancer, arthritis and retinopathy
ABBOTT LAB12 citations73
US5985911ANov 16, 1999
C-terminal ketone inhibitors of matrix metalloproteinases and TNFα secretion
ABBOTT LAB10 citations72
US5459152AOct 17, 1995
Platelet activating factor antagonists
ABBOTT LAB8 citations72
US5120749AJun 9, 1992
Platelet activating antagonists
ABBOTT LAB5 citations62
US5382670AJan 17, 1995
Platelet activating factor antagonists
ABBOTT LAB4 citations61
US8354422B2Jan 15, 2013
Pyrimidine inhibitors of kinase activity
ABBOTT LAB2 citations50
ABBVIE INC
9 patentsUS10085985B2Oct 2, 2018
Bromodomain inhibitors
ABBVIE INC2 citations73
US9493411B2Nov 15, 2016
Pyrrole-3-carboxamide bromodomain inhibitors
ABBVIE INC3 citations72
US9321764B2Apr 26, 2016
Dihydro-pyrrolopyridinone inhibitors
ABBVIE INC3 citations72
US9296741B2Mar 29, 2016
Bromodomain inhibitors
ABBVIE INC7 citations72
US9050346B2Jun 9, 2015
Bromodomain inhibitors
ABBVIE INC5 citations72
US9561231B2Feb 7, 2017
Pyridinone and pyridazinone derivatives
ABBVIE INC4 citations71
US10035800B2Jul 31, 2018
Substituted 1,4,10-triazadibenzo[cd,f]azulenes, substituted 1,4,5,10-tetraazadibenzo[cd,f]azulenes and substituted 1,4,5,7,10-pentaazadibenzo[cd,f]azulenes as bromodomain inhibitors
ABBVIE INC3 citations70
US9776990B2Oct 3, 2017
Isoindolone derivatives
ABBVIE INC1 citations52
US9428514B2Aug 30, 2016
Bromodomain inhibitors
ABBVIE INC1 citations52